66 related articles for article (PubMed ID: 16352778)
1. Adherence to lipid-lowering therapy and reaching treatment goals in youth seen in a preventive cardiology clinic.
Hartz J; Ryan H; Huang Y; Baker A; Bachman J; McAuliffe E; de Ferranti S
Res Social Adm Pharm; 2023 Mar; 19(3):547-549. PubMed ID: 36543634
[TBL] [Abstract][Full Text] [Related]
2. The new lipid guidelines: what do primary care clinicians think?
Jamé S; Wittenberg E; Potter MB; Fleischmann KE
Am J Med; 2015 Aug; 128(8):914.e5-914.e10. PubMed ID: 25837518
[TBL] [Abstract][Full Text] [Related]
3. Evolution of lipid management guidelines: evidence might set you free.
Bosomworth NJ
Can Fam Physician; 2014 Jul; 60(7):612-7, e333-9. PubMed ID: 25022632
[TBL] [Abstract][Full Text] [Related]
4. Application of the very high risk criterion and evaluation of cholesterol guideline adherence in acute myocardial infarction patients at an urban academic medical center.
Brownstein AJ; Derenbecker R; Gao Y; Ding J; Varghese B; Isakadze N; Spaulding EM; Marvel FA; Martin SS
Am Heart J Plus; 2022 Jan; 13():100082. PubMed ID: 38560081
[TBL] [Abstract][Full Text] [Related]
5. Hyperlipidemia medication management in patients admitted for a myocardial infarction.
Shuster JE; Jeffres MN; Barclay SM; Bhakta R
Pharm Pract (Granada); 2011 Jan; 9(1):31-6. PubMed ID: 25132887
[TBL] [Abstract][Full Text] [Related]
6. Modifications of coronary risk factors.
Albu J; Gottlieb SH; August P; Nesto RW; Orchard TJ;
Am J Cardiol; 2006 Jun; 97(12A):41G-52G. PubMed ID: 16813737
[TBL] [Abstract][Full Text] [Related]
7. Management of coronary artery disease in a Tertiary Care Hospital.
Wal P; Wal A; Nair VR; Rai AK; Pandey U
J Basic Clin Pharm; 2013 Mar; 4(2):31-5. PubMed ID: 24808667
[TBL] [Abstract][Full Text] [Related]
8. Attributable Burden and Expenditure of Cardiovascular Diseases and Associated Risk Factors in Mexico and other Selected Mega-Countries.
Mendoza-Herrera K; Pedroza-Tobías A; Hernández-Alcaraz C; Ávila-Burgos L; Aguilar-Salinas CA; Barquera S
Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31652519
[TBL] [Abstract][Full Text] [Related]
9. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
Fazio S
Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
[TBL] [Abstract][Full Text] [Related]
10. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
[TBL] [Abstract][Full Text] [Related]
11. Assessment of compliance with lipid guidelines in an academic medical center.
Schwiesow SJ; Nappi JM; Ragucci KR
Ann Pharmacother; 2006 Jan; 40(1):27-31. PubMed ID: 16352778
[TBL] [Abstract][Full Text] [Related]
12. Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals.
Waters DD; Brotons C; Chiang CW; Ferrières J; Foody J; Jukema JW; Santos RD; Verdejo J; Messig M; McPherson R; Seung KB; Tarasenko L;
Circulation; 2009 Jul; 120(1):28-34. PubMed ID: 19546386
[TBL] [Abstract][Full Text] [Related]
13. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
Gitt AK; Juenger C; Jannowitz C; Karmann B; Senges J; Bestehorn K
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876
[TBL] [Abstract][Full Text] [Related]
14. Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting.
Mosca L; Merz NB; Blumenthal RS; Cziraky MJ; Fabunmi RP; Sarawate C; Watson KE; Willey VJ; Stanek EJ
Circulation; 2005 Feb; 111(4):488-93. PubMed ID: 15687138
[TBL] [Abstract][Full Text] [Related]
15. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
